To ask the Secretary of State for Health, when he expects the Joint Committee on Vaccination and Innoculation to make a recommendation on whether all adolescent boys should be included in the national HPV vaccination programme.
5 January 2015
The Joint Committee on Vaccination and Immunisation (JCVI), the body that advises the government on all immunisation matters has set up a human papillomavirus (HPV) sub-committee to consider a number of key issues on HPV vaccination, including the routine vaccination of adolescent boys.
The HPV sub-committee will report its findings to the JCVI following consideration of work modelling the impact and cost-effectiveness of extending HPV vaccination to adolescent boys. We are advised that it is currently anticipated that a model being developed at Warwick University can be presented to the HPV sub-committee in the second half of 2015. A separate model being developed by Public Health England may not be completed until early 2017.
We are furthermore advised that the JCVI and sub-committee may need to consider both studies before taking a final view on the impact and cost-effectiveness of extending HPV vaccination to adolescent boys and may therefore not be in a position to do so before early 2017.